Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

OM-174 shows in vivo antitumor activity

March 15, 1996

Glaxo Wellcome reports antitumor drugs

March 15, 1996

Marimastat enters phase II in U.S.

March 15, 1996

Techniclone establishes distribution agreement for Oncolym

March 15, 1996

New antimitotic drugs from Pharmacia & Upjohn

March 15, 1996

More approvals for Taxotere

March 15, 1996

Paclitaxel derivatives from Bristol-Myers Squibb

March 15, 1996

FDA gives green light to Immunex's etoposide

March 15, 1996

European clinical trial results with irinotecan reported

March 15, 1996

PK1 to enter phase II

March 15, 1996

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 12, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...